Elevated production of the cytokines CXCL8 and CXCL1 have been implicated in autocrine-based drug resistance in various tumor cell lines [24,26] and in poor clinical outcome in ovarian cancer patients [79]. This evidence concerns the gene CXCL8 and ovarian cancer.